NorthStar Medical Radioisotopes LLC

5249 Femrite Drive
Madison, WI 53718
Phone:
608.230.7160
Fax:
608.230.7180
http://northstarnm.com/

RELATED CONTENT

Under the new agreement, NorthStar will manufacture and distribute patient doses for ongoing Curadh Ac-225 clinical studies and provide Ac-225 for commercial use upon NorthStar’s submission of a Type II Drug Master File (DMF) to the FDA
News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes and Curadh MTR Enter Strategic ...

January 5, 2024 — NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and ...

Time January 05, 2024
Read more
NorthStar’s high purity non-carrier added (n.c.a.) Ac-225 to be used in Curadh’s molecularly targeted radiation (MTR) programs for treatment of solid tumors
News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes and Curadh MTR Announce a Strategic ...

August 31, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time August 31, 2023
Read more
First participant of cohort 4 of the theranostic CL04 trial investigating 64Cu/67Cu SARTATE in neuroblastoma has been treated at the highest dose cohort of 375MBq/kg body weight using NorthStar’s electron accelerator-produced Cu-67, marking a key milestone in NorthStar’s agreement to exclusively supply Cu-67 to Clarity
News | Radiopharmaceuticals and Tracers

First Participant Treated Using NorthStar Medical Radioisotopes’ ...

August 29, 2023 — NorthStar Medical Radioisotopes, LLC (“NorthStar"), a global innovator in the development, production ...

Time August 29, 2023
Read more
First participant of cohort 4 of the theranostic CL04 trial investigating 64Cu/67Cu SARTATE in neuroblastoma has been treated at the highest dose cohort of 375MBq/kg body weight using NorthStar’s electron accelerator-produced Cu-67, marking a key milestone in NorthStar’s agreement to exclusively supply Cu-67 to Clarity
News | Radiopharmaceuticals and Tracers

Carolina Breast Imaging Specialists, PLLC Is First in Nation to Adopt ...

August 29, 2023 — Mammograms are an essential part of preventive healthcare, and when an initial review reveals a ...

Time August 29, 2023
Read more
NorthStar’s non-carrier added (n.c.a.) Ac-225 to be used in Bayer’s radiopharmaceutical programs
News | Molecular Imaging

NorthStar Medical Radioisotopes Executes Supply Agreement with Bayer ...

July 18, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time July 18, 2023
Read more
NorthStar’s high purity non-carrier-added (n.c.a.) Ac-225 to be used in advancing Nucleus’ partners radioligand therapies to treat cancer
News | Molecular Imaging

NorthStar Medical Radioisotopes Announces Supply Agreement with ...

July 5, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time July 05, 2023
Read more
Planned transition part of NorthStar’s strategy for continued growth and industry leadership in domestic radioisotope production and radiopharmaceutical development to meet needs of patients, pharmaceutical companies and radiopharmacies
News | Radiopharmaceuticals and Tracers

NorthStar Medical Technologies, LLC Appoints Frank Scholz, PhD, as ...

June 19, 2023 — NorthStar Medical Technologies, LLC, a global innovator in the development, production and ...

Time June 19, 2023
Read more
NorthStar Medical Radioisotopes has expanded its management team with the appointment of Jean-Noel David, MBA, MS, as Vice President, Operations.
News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes Expands Management Team with ...

April 24, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time April 24, 2023
Read more
New radiopharmaceutical Contract Development and Manufacturing Organization (CDMO/CMO) provides powerhouse combination of capabilities and expertise to advance patient care
News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes Provides Updates on Corporate Progress ...

April 3, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time April 03, 2023
Read more
Proprietary electron accelerator technology achieves “two beams on target” milestone, validating proof of concept for large-scale U.S. Mo-99 production without the use of uranium
News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes Sets New Industry Precedent in ...

January 11, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time January 11, 2023
Read more
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now